Company intelligence / Profile preview

Benuvia

Round Rock, Texas, United Statesbenuvia.com ↗

Ownership: Private
Employees: ~36
Development stage: Commercial

Overview

Benuvia develops, manufactures, and supplies pharmaceutical cannabinoids and controlled substances. Its lead commercial product is SYNDROS® (dronabinol oral solution), FDA-approved for chemotherapy-induced nausea/vomiting in cancer patients and loss of appetite in AIDS. The company also provides end-to-end CDMO services specializing in small molecules—especially controlled substances such as cannabinoids and psychedelics—and supports clients from preclinical through commercial stages. It operates cGMP facilities registered with the DEA/FDA/EPA/OSHA.

Therapeutic areas: OncologyRare DiseasesNeurologyInfectious Diseases
Modalities: Small moleculeBiologic (for cannabinoid-based drugs)Synthetic cannabinoidPsychedelic compounds
Industry: Biotech

Drug pipeline

1 asset

dronabinol

Commercial

Indications: Chemotherapy-induced nausea and vomiting, AIDS-related anorexia

Partnerships

No major pharma partnerships publicly disclosed; business combination agreement announced with Pono Capital Corp. but no evidence deal closed yet.

Beyond the preview

Go deeper on Benuvia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benuvia.

Explore the full profile